Smartphone app helps those with advanced cancer maintain quality of life

by Dennis ThompsonA smartphone app can help individuals with advanced cancer deal with symptoms and maintain their quality of life, according to new research.TheSUPPORT+ appasks them each week to comp

Updated on: August 15,2026

Smartphone app helps those with advanced cancer maintain quality of life

by Dennis ThompsonA smartphone app can help individuals with advanced cancer deal with symptoms and maintain their quality of life, according to new research.TheSUPPORT+ appasks them each week to comp

Updated on:August 15,2026

Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

by Christopher Lieu,The ConversationKRAS (blue) has been difficult for drugs to target. Credit:Fvasconcellos/Wikimedia CommonsFor a long time, the likelihood of surviving pancreatic cancer has been ex

Updated on: August 19,2026

Drug nearly doubles survival in advanced pancreatic cancer—how daraxonrasib overcame an 'undruggable' disease

by Christopher Lieu,The ConversationKRAS (blue) has been difficult for drugs to target. Credit:Fvasconcellos/Wikimedia CommonsFor a long time, the likelihood of surviving pancreatic cancer has been ex

Updated on:August 19,2026

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Updated on: July 18,2026

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Updated on:July 18,2026

New breakthrough in developing more personalized treatments for lung cancer

byUniversity of BarcelonaSummary of the major findings of this study on the histotype-dependent patterns of SMAD2/3 signaling and their relation with angiogenesis/hypoxia regulation in lung TAFs. Cred

Updated on: August 19,2026

New breakthrough in developing more personalized treatments for lung cancer

byUniversity of BarcelonaSummary of the major findings of this study on the histotype-dependent patterns of SMAD2/3 signaling and their relation with angiogenesis/hypoxia regulation in lung TAFs. Cred

Updated on:August 19,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on: August 06,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on:August 06,2026

Study reveals asbestos blind spot in lung cancer screening may cost lives

by Laura Thomas,Curtin UniversityCredit: Sonny Sixteen from PexelsNew Curtin University research has found Australians exposed to asbestos could be falling through the cracks of lung cancer screening

Updated on: August 18,2026

Study reveals asbestos blind spot in lung cancer screening may cost lives

by Laura Thomas,Curtin UniversityCredit: Sonny Sixteen from PexelsNew Curtin University research has found Australians exposed to asbestos could be falling through the cracks of lung cancer screening

Updated on:August 18,2026

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat

Updated on: June 18,2026

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat

Updated on:June 18,2026

Serious infection risks linked to targeted cancer therapies

by Carly Murphy,University of California, IrvineCredit: Thirdman from PexelsA major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effec

Updated on: August 20,2026

Serious infection risks linked to targeted cancer therapies

by Carly Murphy,University of California, IrvineCredit: Thirdman from PexelsA major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effec

Updated on:August 20,2026

Blood test spots 14 proteins that predict lung cancer risk up to five years early

byThe Francis Crick InstituteGraphical abstract. Credit:Cell(2026). DOI: 10.1016/j.cell.2026.05.005As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start

Updated on: August 19,2026

Blood test spots 14 proteins that predict lung cancer risk up to five years early

byThe Francis Crick InstituteGraphical abstract. Credit:Cell(2026). DOI: 10.1016/j.cell.2026.05.005As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start

Updated on:August 19,2026

Worm tablet could be repurposed as brain cancer treatment

byBond UniversityBlood–brain barrier efflux limits brain penetration of mebendazole polymorph C, whereas elacridar increases central nervous system exposure. Credit:British Journal of Clinical Pharmac

Updated on: August 20,2026

Worm tablet could be repurposed as brain cancer treatment

byBond UniversityBlood–brain barrier efflux limits brain penetration of mebendazole polymorph C, whereas elacridar increases central nervous system exposure. Credit:British Journal of Clinical Pharmac

Updated on:August 20,2026

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted

Updated on: August 20,2026

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted

Updated on:August 20,2026

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

Updated on: July 28,2026

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

Updated on:July 28,2026